Orexin-SAP References

Cat #IT-20

2019

Benade V, Daripelli S, Tirumalasetty C, Subramanian R, Petlu S, Badange R, & Nirogi R. 0054 SUVN-G3031, a Histamine H3 Receptor Inverse Agonist Produces Wake Promoting Effect in Orexin-2-saporin Lesioned Rats. (2019). Sleep, 42 (Supplement_1):A22-A23.

Summary:  Rats lesioned with Orexin-SAP in lateral hypothalamus produced narcoleptic-like behavior.

Nirogi R, Shinde AK, Mohammed AR, Badange RK, Reballi V, Bandyala TR, Saraf SK, Bojja K, manchineella s, Achanta PK, Kandukuri KK, Subramanian R, Benade V, Palacharla RC, Jayarajan P, Pandey S, & Jasti V. Discovery and Development of N-[4-(L-Cyclobutylpiperidin-4-Yloxy) Phenyl]-2-(Morpholin-4-Yl) Acetamide Dihydrochloride (Suvn-G3031): A Novel, Potent, Selective and Orally Active Histamine H3 Receptor Inverse Agonist with Robust Wake-Promoting Activity. (2019). J Med Chem, ePub 10 January 

Objective:  To discover and develop a therapeutic for human sleep disorders.
Summary:  Histamine H3 Receptor Inverse Agonist demonstrated high receptor occupancy and marked wake promoting effects with decreased  REM sleep in Orexin-B-SAP lesioned rats. This study supports its potential therapeutic utility in treating human sleep disorders.
Dose:  Injections (490 ng/0.8 μl) were made bilaterally to the lateral hypothalamus.

2018

Oliveira LM, Falquetto B, Moreira TS, & Takakura AC. Orexinergic Neurons Are Involved in the Chemosensory Control of Breathing During the Dark Phase in a Parkinson’s Disease Model. (2018). Experimental Neurology, 309 107-118.

Objective:  To determine the involvement of orexin cells from the lateral hypothalamus/perifornical area (LH/PeF) on breathing.
Summary:  The degeneration of orexinergic neurons in this model of PD can be related to impaired chemoreceptor function in the dark phase.
Dose:  For lesions of LH/PeF, two injections of Orexin-B-SAP or Rabbit IgG-SAP (100 ng/μl) were made into the lateral hypothalamus / perifornical area (LH/PeF).

Arias-Carrion O, Ortega-Robles E, de Celis-Alonso B, Palasz A, Mendez-Rojas MA, Salas-Pacheco J, & Murillo-Rodriguez E. Depletion of Hypocretin/Orexin Neurons Increases Cell Proliferation in the Adult Subventricular Zone. (2018). CNS & Neurological Disorders – Drug Targets- CNS & Neurological Disorders), 17 (2):106-112.

Objective:  To establish the relationship between the depletion of orexin neurons and the number of proliferating cells in the subventricular zone.
Summary:  The adult subventricular zone is affected by orexinergic signaling, the functional implication of which must be further elucidated.
Dose:  90 ng of Orexin-SAP or pyrogen-free saline was stereotaxically injected into the lateral hypothalamus (3.2 caudal, 1.7 lateral to bregma, 8.1 ventral to the skull surface) of male Wistar rats.

2016

Mohammed M, Kulasekara K, Ootsuka Y, Blessing WW. (2016) Locus coeruleus noradrenergic innervation of the amygdala facilitates alerting-induced constriction of the rat tail artery. Am J Physiol Regul Integr Comp Physiol 310(11):R1109-19. PMID: 27101292 (Targeting Trends 16q3)

Schwartz MD, Nguyen AT, Warrier DR, Palmerston JB, Thomas AM, Morairty SR, Neylan TC, Kilduff TS. (2016) Locus Coeruleus and Tuberomammillary Nuclei Ablations Attenuate Hypocretin/Orexin Antagonist-Mediated REM Sleep. eNeuro 3(2) PMID: 27022631 (Targeting Trends 16q2)

2014

Arias-Carrion O, Murillo-Rodriguez E. (2014) Effects of hypocretin/orexin cell transplantation on narcoleptic-like sleep behavior in rats. PLoS One 9(4):e95342. (Targeting Trends 14q3)

Vetrivelan R, Saper CB, Fuller PM. (2014) Armodafinil-induced wakefulness in animals with ventrolateral preoptic lesions. Nat Sci Sleep 6:57-63. (Targeting Trends 14q3)

Wheeler DS, Wan S, Miller A, Angeli N, Adileh B, Hu W, Holland PC. (2014) Role of lateral hypothalamus in two aspects of attention in associative learning. Eur J Neurosci 40(2):2359-2377. (Targeting Trends 14q3)

Zhang GH, Liu ZL, Zhang BJ, Geng WY, Song NN, Zhou W, Cao YX, Li SQ, Huang ZL, Shen LL. (2014) Orexin A activates hypoglossal motoneurons and enhances genioglossus muscle activity in rats. Br J Pharmacol 171(18):4233-4246. (Targeting Trends 14q3)

2013

Kukkonen JP. (2013) Physiology of the orexinergic/hypocretinergic system: a revisit in 2012. Am J Physiol Cell Physiol 304(1):C2-32. (Targeting Trends 13q2)

2012

Anaclet C, Lin JS, Vetrivelan R, Krenzer M, Vong L, Fuller PM, Lu J. (2012) Identification and characterization of a sleep-active cell group in the rostral medullary brainstem. J Neurosci 32(50):17970-17976. (Targeting Trends 13q1)

Brown RE, Basheer R, McKenna JT, Strecker RE, McCarley RW. (2012) Control of sleep and wakefulness. Physiol Rev 92(3):1087-1187. (Targeting Trends 12q4)

Ma J, Tai SK, Leung LS. (2012) Septohippocampal GABAergic neurons mediate the altered behaviors induced by n-methyl-D-aspartate receptor antagonists. Hippocampus 22(12):2208-2218. (Targeting Trends 12q4)

Olarte-Sanchez C, Valencia Torres L, Body S, Cassaday H, Bradshaw C, Szabadi E. (2012) Effect of orexin-B-saporin-induced lesions of the lateral hypothalamus on performance on a progressive ratio schedule. J Psychopharmacol 26(6):871-886. (Targeting Trends 11q4)

Vetrivelan R, Fuller PM, Yokota S, Lu J, Saper CB. (2012) Metabolic effects of chronic sleep restriction in rats. Sleep 35(11):1511-1520. (Targeting Trends 13q1)

2011

Di Sebastiano AR, Wilson-Perez HE, Lehman MN, Coolen LM (2011) Lesions of orexin neurons block conditioned place preference for sexual behavior in male rats. Horm Behav 59(1):1-8. (Targeting Trends 11q1)

I’anson H, Jethwa PH, Warner A, Ebling FJ. (2011) Histaminergic regulation of seasonal metabolic rhythms in Siberian hamsters. Physiol Behav 103(3-4):268-278. (Targeting Trends 11q2)

Lecourtier L, de Vasconcelos AP, Leroux E, Cosquer B, Geiger K, Lithfous S, Cassel JC. (2011) Septohippocampal pathways contribute to system consolidation of a spatial memory: Sequential implication of gabaergic and cholinergic neurons. Hippocampus 21(12):1277-1289. (Targeting Trends 10q4)

Luo T, Leung LS. (2011) Involvement of Tuberomamillary Histaminergic Neurons in Isoflurane Anesthesia. Anesthesiology 115(1):36-43. (Targeting Trends 11q3)

Ocampo-Garces A, Ibanez F, Perdomo G, Torrealba F (2011) Orexin-B-saporin lesions in the lateral hypothalamus enhance photic masking of rapid eye movement sleep in the albino rat. J Sleep Res20(1 Pt 1):3-11. (Targeting Trends 10q4)

2010

Di Sebastiano AR, Yong-Yow S, Wagner L, Lehman MN, Coolen LM (2010) Orexin mediates initiation of sexual behavior in sexually naive male rats, but is not critical for sexual performance. Horm Behav 58(3):397-404. (Targeting Trends 10q3)

Luo T, Leung LS (2010) Endogenous Histamine Facilitates Long-Term Potentiation in the Hippocampus during Walking. J Neurosci 30(23):7845-7852. (Targeting Trends 10q3)

2009

Arias-Carrion O, Murillo-Rodriguez E (2009) Cell transplantation: a future therapy for narcolepsy? CNS Neurol Disord Drug Targets 8:309-314. (Targeting Trends 10q1)

Kaur S, Thankachan S, Begum S, Liu M, Blanco-Centurion C, Shiromani PJ (2009) Hypocretin-2 saporin lesions of the ventrolateral periaquaductal gray (vlPAG) increase REM sleep in hypocretin knockout mice. PLoS One 4:e6346. (Targeting Trends 09q4)

Vetrivelan R, Fuller PM, Tong Q, Lu J (2009) Medullary circuitry regulating rapid eye movement sleep and motor atonia. J Neurosci 29:9361-9369. (Targeting Trends 09q4)

See also: Society for Neuroscience 2009 Abstracts

2008

Murillo-Rodriguez E, Liu M, Blanco-Centurion C, Shiromani PJ (2008) Effects of hypocretin (orexin) neuronal loss on sleep and extracellular adenosine levels in the rat basal forebrain. Eur J Neurosci 28(6):1191-1198. (Targeting Trends 08q4)

See also: Society for Neuroscience 2008 Abstracts

2007

Blanco-Centurion C, Gerashchenko D, Shiromani PJ (2007) Effects of saporin-induced lesions of three arousal populations on daily levels of sleep and wake. J Neurosci 27:14041-14048. (Targeting Trends 08q1)

Frederick-Duus D, Guyton MF, Fadel J (2007) Food-elicited increases in cortical acetylcholine release require orexin transmission. Neuroscience 149:499-507. (Targeting Trends 08q1)

Furlong T, Carrive P (2007) Neurotoxic lesions centered on the perifornical hypothalamus abolish the cardiovascular and behavioral responses of conditioned fear to context but not of restraint. Brain Res 1128(1):107-119. (Targeting Trends 07q1)

See also: Society for Neuroscience 2007 Abstracts

2006

Easton A, Dwyer E, Pfaff DW (2006) Estradiol and orexin-2 saporin actions on multiple forms of behavioral arousal in female mice. Behav Neurosci 120(1):1-9. (Targeting Trends 06q2)

Gerashchenko D, Blanco-Centurion CA, Miller JD, Shiromani PJ (2006) Insomnia following hypocretin2-saporin lesions of the substantia nigra. Neuroscience 137(1):29-36. (Targeting Trends 06q1)

Lu J, Sherman D, Devor M, Saper CB (2006) A putative flip-flop switch for control of REM sleep. Nature 441(1):589-594. (Targeting Trends 07q1)

See also: Society for Neuroscience 2006 Abstracts

2005

Gerashchenko D, Chou TC, Blanco-Centurion CA, Saper CB, Shiromani PJ (2004) Effects of lesions of the histaminergic tuberomammillary nucleus on spontaneous sleep in rats. Sleep 27(7):1275-1281. (Targeting Trends 05q2)

Lappi DA (2005) Targeted Toxins from Here to There. Targeting Trends 6(3):1, 6.

Pang K, Smith H. (2005) Effects of Intraseptal Orexin-Saporin on Spatial Memory. Targeting Trends 6(4).

Smith HR, Pang KC (2005) Orexin-saporin lesions of the medial septum impair spatial memory. Neuroscience 132(2):261-271. (Targeting Trends 05q3)

See also: Society for Neuroscience 2005 Abstracts

2004

Blanco-Centurion C, Gerashchenko D, Salin-Pascual RJ, Shiromani PJ (2004) Effects of hypocretin2-saporin and antidopamine-beta-hydroxylase-saporin neurotoxic lesions of the dorsolateral pons on sleep and muscle tone. Eur J Neurosci 19(10):2741-2752. (Targeting Trends 04q3)

2003

Gerashchenko K, Blanco-Centurion C, Greco MA, Shiromani PJ (2003) Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats. Neuroscience 116:223-235. (Targeting Trends 03q2)

Gerashchenko D, Murillo-Rodriguez E, Lin L, Xu M, Hallett L, Nishino S, Mignot E, Shiromani PJ (2003) Relationship between CSF hypocretin levels and hypocretin neuronal loss. Exp Neurol 184(2):1010-1016. (Targeting Trends 04q2)

Mistlberger RE, Antle MC, Kilduff TS, Jones M (2003) Food- and light-entrained circadian rhythms in rats with hypocretin-2-saporin ablations of the lateral hypothalamus. Brain Res 980(2):161-168. (Targeting Trends 03q3)

See also: Society for Neuroscience 2003 Abstracts

2002

Blanco-Centurion C. (2002) HCRT-SAP Lesion Produces Sleepiness While anti-DBH-SAP Lesion Does Not. Targeting Trends 3(2).

See: Society for Neuroscience 2002 Abstracts

2001

Gerashchenko D, Kohls MD, Greco M, Waleh NS, Salin-Pascual R, Kilduff TS, Lappi DA, Shiromani PJ (2001) Hypocretin-2-Saporin Lesions of the Lateral Hypothalamus Produce Narcoleptic-Like Sleep Behavior in the Rat. J Neurosci 21(18):7273-7283. (Targeting Trends 01q4)

See also: Society for Neuroscience 2001 Abstracts

Gerashchenko D, Salin-Pascual R, Shiromani PJ (2001) Effects of Hypocretin-Saporin Injections into the Medial Septum on Sleep and Hippocampal Theta. Brain Res 913:106-115. (Targeting Trends 01q4)

See also: Society for Neuroscience 2000 Abstracts

1998

Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson s, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573-585.